Related Experiment Videos
[Long-term effect of polystan monocusp ventricular outflow patch after right ventricular outflow tract
T Sugita1, M Matsumoto, H Ogino
1Department of Cardiovascular Surgery, Tenri Hospital, Nara, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|September 22, 2000
Summary
This study on Monocusp Ventricular Outflow Patch (MVOP) surgery found no late deaths but identified pulmonary regurgitation as a significant long-term issue, impacting right ventricular outflow tract reconstruction outcomes.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Biomaterials in Medicine
Context:
- Right ventricular outflow tract reconstruction is a critical procedure in congenital heart disease.
- The Monocusp Ventricular Outflow Patch (MVOP) has been used for this purpose.
- Long-term outcomes and potential complications require thorough evaluation.
Purpose:
- To assess the long-term efficacy and complications of MVOP in right ventricular outflow tract reconstruction.
- To identify the primary causes of reoperation and long-term adverse events.
- To evaluate the incidence and severity of pulmonary regurgitation after MVOP surgery.
Summary:
- This review analyzed 48 patients undergoing 55 MVOP procedures for right ventricular outflow tract reconstruction.
- No late deaths occurred, with a 5- and 10-year freedom from reoperation rate of 97.2% and 80.7%, respectively.
- The main reoperation cause was right ventricular outflow obstruction (RVOTO), often a technical issue, though absent in recent cases. Pulmonary regurgitation worsened significantly over time, becoming the primary long-term concern.
Impact:
- Findings highlight pulmonary regurgitation as a major challenge in long-term MVOP outcomes.
- Identifies potential technical improvements to mitigate RVOTO.
- Informs surgical decision-making and follow-up strategies for patients with RVOT defects.